Reciprocal activation of human t-lymphotropic viruses in htlv-i-transformed cells superinfected with hiv-1

Journal of Acquired Immune Deficiency Syndromes

Volumn 4, Issue 4, 1991, Pages 380-385

  Rossi, Anita De ^a   Saggioro, Daniela ^a   Calabr Ó, Maria Luisa ^a   Cenzato, Remigio ^a   Chieco Bianchi, Luigi ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Double infection; HIV 1; HTLV I; Reciprocal activation

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 1; SUPERINFECTION; VIRUS ACTIVATION; VIRUS CELL TRANSFORMATION; VIRUS INFECTION;

CELL LINE, TRANSFORMED; GENE PRODUCTS, TAT; GENE PRODUCTS, TAX; HIV-1; HUMAN; HUMAN T-LYMPHOTROPIC VIRUS 1; NUCLEIC ACID HYBRIDIZATION; RNA, VIRAL; SUPERINFECTION; SUPPORT, NON-U.S. GOV'T; TRANSFECTION; VIRUS ACTIVATION;

HTLV; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 0026101315     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Poiesz BJ, Ruscetti FW, Gadzar AF, Bunn PA, Minua JD, Gallo RC. Detection and isolation of type-C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980; 77:7415-9.
2. Yoshida M, Miyoshi I, Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA 1982; 79:2031-5.
3. BarréSinoussi F, Cherman JC, Rey F. Isolation of a Tlymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome. Science 1983; 220:868-70.
4. Popovic M, Sargadharan MG, Read E, Gallo RC. Detection, isolation and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 1984; 224:497-500.
5. Wong-Staal F, Gallo RC. Human T-lymphotropic retroviruses. Nature 1985; 317:395-403.
6. Fauci A. The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science 1988; 239:617-22.
7. Bartholomew C, Blattner W, Cleghorn F. Progression to AIDS in homosexual men co-infected with HIV and HTLV-I in Trinidad. Lancet 1987; 2:1469.
8. Robert-Guroff M, Safai B, Gelmann EP, et al. HTLV-I specific antibody in AIDS patients and others at risk. Lancet 1984; 2:128-30.
9. Tedder RS, Shanson DC, Jeffries DJ, et al. Low prevalence in the UK of HTLV-I and HTLV-III infection in subjects with AIDS, with extended lymphoadenopathy, and at risk of AIDS. Lancet 1984; 2:125-7.
10. De Rossi A, Bortolotti F, Cadrobbi P, Chieco-Bianchi L. Trends of HTLV-I and HIV infections in drug addicts. Eur J Cancer Clin Oncol 1988; 24:279-80.
11. Siekevitz M, Josephs S, Dukovich M, Peffer N, Wong-Staal F, Greene WC. Activation of the HIV-1 LTR by T cell mitogens and the trans-activator protein of HTLV-I. Science 1987; 238:1575-8.
12. Bohnlein E, Siekevitz M, Ballard DW, et al. Stimulation of the human immunodeficiency virus type 1 enhancer by the human T cell leukemia type 1 tax gene product involves the action of inducible cellular proteins. J Virol 1989; 63:1578-86.
13. Clumeck N. The epidemic of AIDS virus infection. What is the interest for the oncologists? Eur J Cancer Clin Oncol 1987; 23:115-7.
14. Levine AM. Reactive and neoplastic lymphoproliferative disorders and other miscellaneous cancers associated with HIV infection. In: De Vita VT, Hellman S, Rosenberg SA, eds. AIDS: etiology, diagnosis, treatment and prevention. 2nd ed. New York: JB Lippincott, 1988:263-75.
15. Miyoshi I, Kubonishi I, Yoshimoto S, Akagi T, Ontusuki Y, Shiraishi Y. Type C particles in a cord T cell line derived by cocultivating normal human cord leukocytes and human leukaemic T cells. Nature 1981; 294:770-1.
16. Salahuddin SZ, Markham PD, Wong-Staal F, Franchini G, Kalyanaraman VS, Gallo RC. Restriction expression of human T-cell leukemia-lymphoma virus (HTLV) in transformed human umbilical cord blood lymphocytes. Virology 1983; 129:51-64.
17. Paeratakul U, De Stasio PR, Taylor MW. A fast and sensitive method for detecting specific viral RNA in mammalian cells. J Viro 1988; 62:1132-5.
18. Manzari V, Wong-Staal F, Franchini G, et al. Human T cell leukemia/lymphoma virus (HTLV): cloning of an integrated defective provirus and flanking cellular sequences. Proc Natl Acad Sci USA 1983; 80:1574-8.
19. Hahn BH, Shaw GM, Arya SK, Popovic M, Gallo RC, Wong-Staal F. Molecular cloning and characterization of the HTLV-III virus associated with AIDS. Nature 1984; 312:166-9.
20. De Rossi A, Franchini G, Aldovini A, et al. Differential response to the cytopathic effects of human T-cell lymphotropic virus type III (HTLV-III) superinfection in T4+ (helper) and T8 + (suppressor) T cell clones transformed by HTLV-I. Proc Natl Acad Sci USA 1986; 83:4297-301.
21. Harada S, Koyanagi Y, Yamamoto N. Infection of HT-LVIII/LAV in HTLV-I carrying cells MT-2 and MT-4 and application in a plaque assay. Science 1985; 229:563-6.
22. Saggioro D, Panozzo M, Chieco-Bianchi L. HTLV-I transcriptional regulation by methylation. Cancer Res 1990; 50: 4968-73.
23. Amadori A, Faulkner-Valle G, De Rossi A, Zanovello P, Collavo D, Chieco-Bianchi L. HIV-mediated immunodepression: in vitro inhibition of T-lymphocyte proliferative response by ultraviolet-inactivated virus. Clin Immunol Immunopathol 1988; 46:37-54.
24. Sodroski JG, Rosen CA, Haseltine WA. Trans-acting transcriptional activation of the long terminal repeat of human T-lymphotropic viruses in infected cells. Science 1984; 225; 381-5.
25. Arya SK, Guo C, Josephs SF, Wong-Staal F. Transactivator gene of human T-lymphotropic virus type III (HTLV-III). Science 1985; 229:69-73.
26. Gorman CM, Moffat LF, Howard BH. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol 1982; 2:1044-51.
27. Sodroski J, Rosen C, Wong-Staal F, et al. Trans-acting transcriptional regulation of human T cell leukemia virus type III long terminal repeat. Science 1985; 227:171-3.
28. Jeang K-T, Boros I, Brady J, Radonovich M, Khoury G. Characterization of cellular factors that interact with the human T-cell leukemia virus type I p40x-responsive 21-base-pair sequence. J Virol 1988; 62:4499-509.
29. Tan T, Horikoshi M, Roeder RG. Purification and characterization of multiple nuclear factors that bind to the tax-inducible enhancer within the human T-cell leukemia virus type 1 long terminal repeat. Mol Cell Biol 1989; 9:1733-45.
30. Nabel G, Baltimore D. An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature 1987; 326:71-3.
31. Greene WC, Bohnlein E, Ballard D. HIV-1, HTLV-I and normal T-cell growth: transcriptional strategies and surprises. Immunol Today 1989; 10:272-7.
32. McDonald JF, Josephs SF, Wong-Staal F, Strand DJ. HIV-1 expression is post transcriptionally repressed in Drosophila cells. AIDS Res Hum Retrovirus 1989; 5:79-85.
33. Cohen EA, Terwilliger EF, Jalinoos Y, Proulx J, Sodroski JG, Haseltine WA. Identification of HIV-1 vpr product and function. J Acq Immun Def Synd 1990; 3:11-8.
34. Cohen EA, Dehni G, Sodroski JG, Haseltine WA. Human immunodeficiency virus vpr product is a virion-associated regulatory protein. J Virol 1990; 64:3097-9.
35. Zack JA, Cann AJ, Lugo JP, Chen ISY. HIV-1 production from infected peripheral blood T cell after HTLV-I induced mitogenic stimulation. Science 1988; 240:1026-9.